Cyprolidol
Cyprolidol is an orally active inhibitor of acetylcholine receptor and histamine receptor with potential antidepressant activity. Cyprolidol inhibits acetylcholine-induced hypotensive response, histamine-induced systolic blood pressure decrease, tyramine-induced systolic blood pressure increase, serotonin-induced systolic blood pressure response in anesthetized animals, and bretylium-induced systolic blood pressure increase in anesthetized cats. Cyprolidol potentiates norepinephrine-induced systolic blood pressure increase, slightly potentiates epinephrine-induced systolic blood pressure increase, and enhances the anesthetic depth of barbiturates. Cyprolidol can be used in the research of depression.
For research use only. We do not sell to patients.
- CAS No.: 4904-00-1
- Formula: C21H19NO
- Molecular Weight:301.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
All Histamine Receptor Isoforms
More
Biological Activity
Description
In Vivo
Cyprolidol (10 mg/kg; i.v.; single dose) produces a mean -34.16 mmHg systolic pressure fall in anesthetized dogs, while also potentiating norepinephrine and epinephrine pressor responses and inhibiting tyramine, histamine, acetylcholine, and serotonin responses[1].
Cyprolidol (10-30 mg/kg; i.v.; single dose) produces a biphasic systolic pressure response (-34.00 mmHg fall followed by +38.00 mmHg rise) in anesthetized cats, while also potentiating norepinephrine and epinephrine pressor responses, inhibiting tyramine, histamine, acetylcholine, serotonin, and bretylium responses, and at 30 mg/kg i.v. reversing bretylium-induced pressure rises to falls[1].
Cyprolidol (30 mg/kg; p.o.; daily; 14 days) does not alter normotensive systolic pressure in conscious dogs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 4904-00-1
-
Molecular Weight 301.38
-
Formula C21H19NO
-
SMILES
OC(C1=CC=CC=C1)(C2=CC=CC=C2)[C@H]3[C@H](C4=CC=NC=C4)C3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Protocol for Tail Suspension Test (TST)
The Tail Suspension Test is a mouse behavioral assay in which an animal is suspended by the tail in an inescapable position, causing alternating escape-directed activity and immobility; the main readout is immobility time, and antidepressant-like treatments generally reduce immobility compared with vehicle controls. The assay detects behavioral response to acute inescapable stress rather than a molecular event; immobility is interpreted as passive stress-coping behavior, while reduced immobility is used as a predictive screen for antidepressant-like activity, with important limitations related to strain, locomotor activity, and tail-climbing behavior.
-
Protocol for Forced Swim Test (FST)
The Forced Swim Test is a rodent behavioral assay in which a mouse or rat is placed in an inescapable cylinder of water, and the main readout is the time spent immobile versus active escape-related behaviors such as swimming or climbing. Reduced immobility after treatment has historically been interpreted as antidepressant-like activity, but the assay should be interpreted as a behavioral response to acute inescapable stress rather than a complete model of human depression.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Cyprolidol Related Classifications
HY-184374 Related Classifications
Powered by Bioz